openPR Logo
Press release

AI In Clinical Trials Global Market Analysis, Trends, Growth, Research And Forecast 2033

06-03-2024 01:36 PM CET | Health & Medicine

Press release from: The Business research company

AI In Clinical Trials Global Market

AI In Clinical Trials Global Market

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

AI In Clinical Trials Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $26.77 billion In 2028 At A CAGR Of 41.5%.

The ai in clinical trials market size has grown exponentially in recent years. It will grow from $4.74 billion in 2023 to $6.69 billion in 2024 at a compound annual growth rate (CAGR) of 41.1%. The growth in the historic period can be attributed to data accumulation in healthcare, computing power advancements, fda support for ai, rise of wearable devices, early ai algorithms development.

The ai in clinical trials market size is expected to see exponential growth in the next few years. It will grow to $26.77 billion in 2028 at a compound annual growth rate (CAGR) of 41.5%. The growth in the forecast period can be attributed to real-world data integration, ai-powered patient recruitment, ai-driven biomarker identification, ai-driven trial design optimization, continuous monitoring technology. Major trends in the forecast period include federated learning approaches, ai in adaptive trials, ai-supported outcome prediction, ai-driven drug development, ai-powered drug repurposing.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=11961&type=smp

AI In Clinical Trials Market Major Segments
The ai in clinical trials market covered in this report is segmented -

1) By Offering: Software, Services
2) By Process: Trial Design, Patient Selection, Site Selection, Patient Monitoring
3) By Technology: Machine Learning, Deep Learning, Supervised Learning, Other Technologies
4) By Application: Oncology, Neurological Diseases And Condition, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Immunology diseases, Other Applications
5) By End-User: Pharmaceuticals And Biotechnology Companies, Contract Research Organizations, Other End-Users

Key Driver - AI In Clinical Trials Market Surges With The Escalating Incidence Of Chronic And Infectious Diseases

Rising incidences of chronic and infectious diseases are expected to propel the growth of the AI in clinical trials market going forward. Chronic disease refers to a form of illness that lasts for three months or more and can deteriorate with time. Artificial intelligence in clinical trials is helpful to develop various drugs for treating chronic diseases. For instance, in January 2023, according to the National Library of Medicine, a US-based agency, the number of people in the US aged 50 and older who have at least one chronic condition would increase by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. Therefore, the rising incidences of chronic and infectious diseases are driving the growth of the AI in the clinical trials market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=11961&type=smp

Prominent Trend - Lantern Pharma Unveils Radr AI And ML Platform, Elevating Ai In Clinical Trials For Accelerated Medication Discovery

Technological advancements are a key trend gaining popularity in the AI in clinical trials market. Companies operating in the AI in clinical trials market are adopting new technologies to sustain their position in the market. For instance, in February 2023, Lantern Pharma, a US-based clinical-stage oncology company introduced its unique RADR artificial intelligence ('AI') and machine learning ('ML') platform to revolutionize the expense, speed, and timeframe of oncology medication discovery and development. These RADR developments would concentrate on additional cutting-edge AI and ML methods to create antibody-drug conjugates (ADCs), which are highly targeted antibodies for the treatment of cancer that are connected to effective anti-tumor small molecules.

AI In Clinical Trials Market Players
Major companies operating in the ai in clinical trials market report are Intel, The International Business Machines Corporation (IBM), Koninklijke Philips N.V., ConcertAI, Saama Technologies LLC, Samaa Technologies, Owkin Inc., Numerate, Neuroute, AiCure, Ardigen, Unlearn AI, PathAI, Exscentia, Aitia Infotech Pvt Ltd., Euretos, VeriSIM Life, Envisagenics, NURITAs, BioSymetrics, BioAge Labs Inc, Trials.Ai, Pharmaseal, Caylx, IQVIA

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/ai-in-clinical-trials-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the AI in clinical trials market in 2023. The regions covered in the ai in clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. AI In Clinical Trials Market Report Structure
3. AI In Clinical Trials Market Trends And Strategies
4. AI In Clinical Trials Market - Macro Economic Scenario
5. AI In Clinical Trials Market Size And Growth
…..
27. AI In Clinical Trials Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release AI In Clinical Trials Global Market Analysis, Trends, Growth, Research And Forecast 2033 here

News-ID: 3523227 • Views:

More Releases from The Business research company

Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the Zinc Citrate Market
Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the Z …
The zinc citrate market is set to experience significant growth over the coming years, driven by several health and regulatory factors. With increasing consumer interest in preventive healthcare and clean-label products, this market is evolving rapidly. Let's explore the current market size, major players, emerging trends, and the segments shaping this dynamic industry. Projected Market Value and Growth Trajectory of the Zinc Citrate Market The zinc citrate market is anticipated
Analysis of Key Market Segments Driving the Wood Adhesives Market
Analysis of Key Market Segments Driving the Wood Adhesives Market
The wood adhesives market is positioned for notable growth as industries increasingly focus on sustainable materials and innovative construction methods. With rising demand across various sectors, the market is set to expand substantially through 2030, driven by evolving technologies and environmental considerations. Here is a detailed insight into the market's size, key players, trends, and segment outlook. Projected Expansion of the Wood Adhesives Market by 2030 The wood adhesives market
Market Trend Analysis: The Impact of Recent Innovations on the Waterproofing Admixture Market
Market Trend Analysis: The Impact of Recent Innovations on the Waterproofing Adm …
The waterproofing admixture market is gaining significant traction as construction demands evolve to address climate resilience and sustainability. With innovations in materials and increasing infrastructure investments, this sector is positioned for notable expansion over the coming years. Let's explore the market's projected growth, key players, emerging trends, and important segments shaping its future trajectory. Projected Growth and Market Size of the Waterproofing Admixture Market The waterproofing admixture market is anticipated
Growth Patterns, Market Segmentation, and Competitive Approaches Influencing the Water-Based Adhesives Industry
Growth Patterns, Market Segmentation, and Competitive Approaches Influencing the …
The water-based adhesives market is poised for significant expansion in the coming years, driven by evolving demands and innovative advancements. As industries seek more sustainable and efficient bonding solutions, this sector is set to experience remarkable growth through 2030. Here is a detailed exploration of the market size, key players, emerging trends, and the main segments shaping this dynamic industry. Anticipated Growth Trajectory of the Water-Based Adhesives Market The water-based

All 5 Releases


More Releases for Trial

Clinical Trial Investigative Site Network Market Clinical Trial Investigative Si …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trial Investigative Site Network Market - (By Therapeutic Areas (Oncology, Cardiology, CNS, Pain Management, Endocrine, Others), By Phase (Phase I, Phase II, Phase III, Phase IV), By End-use (Sponsor, CRO)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic, the Global Clinical Trial Investigative Site Network Market
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025? The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025? The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with
Clinical Trial Imaging market
The Clinical Trial Imaging market crossed the US$ 1.09 billion mark in 2022 and is expected to hit US$ 1.94 billion by 2030, recording a CAGR of 7.5% during the forecast period. Rising R&D spending, a rapidly growing pharmaceutical industry, and an increase in the number of contract research organizations are some of the major factors driving the market's growth. There has been an increase in pharmaceutical companies due to the
Clinical Trial Logistics
Clinical Trial Logistics 16th to 17th May 2011, Marriott Regents Park, London, United Kingdom. It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trials
Clinical Trial Logistics
Announcing SMi's 5th annual… Clinical Trial Logistics conference 16th and 17th May 2011, Central London, UK www.smi-online.co.uk/2011logistics-london6.asp It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical